Cargando…
Pretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria
Sapropterin dihydrochloride (BH(4)) reduces phenylalanine (Phe) levels and improves white matter integrity in a subset of individuals with phenylketonuria (PKU) known as “responders.” Although prior research has identified biochemical and genotypic differences between BH(4) responders and non-respon...
Autores principales: | Hawks, Zoë, Shimony, Joshua, Rutlin, Jerrel, Grange, Dorothy K., Christ, Shawn E., White, Desirée A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323508/ https://www.ncbi.nlm.nih.gov/pubmed/28271047 http://dx.doi.org/10.1016/j.ymgmr.2017.01.013 |
Ejemplares similares
-
Relationship between age and white matter integrity in children with phenylketonuria
por: Wesonga, Erika, et al.
Publicado: (2016) -
White and gray matter brain development in children and young adults with phenylketonuria
por: Hawks, Zoë, et al.
Publicado: (2019) -
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
por: Harding, Cary O
Publicado: (2010) -
Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride
por: Douglas, Teresa D, et al.
Publicado: (2013) -
A Prospective Population Pharmacokinetic Analysis of Sapropterin Dihydrochloride in Infants and Young Children with Phenylketonuria
por: Qi, Yulan, et al.
Publicado: (2014)